E-4904

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameE-4904
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTopoisomerase (DNA) II alpha inhibitors
TargetsTopoisomerase (DNA) II alpha
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEsteve Healthcare SL
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEsteve Healthcare SL
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A